Stem Cells Help Heal Lung Injury in Mice
Author Information
Author(s): Kim Eun Sun, Chang Yun Sil, Choi Soo Jin, Kim Jin Kyu, Yoo Hey Soo, Ahn So Yoon, Sung Dong Kyung, Kim Soo Yoon, Park Ye Rim, Park Won Soon
Primary Institution: Samsung Medical Center, Sungkyunkwan University School of Medicine
Hypothesis
Intratracheal transplantation of human umbilical cord blood-derived MSCs could attenuate Escherichia coli-induced acute lung injury in mice by suppressing the inflammatory response.
Conclusion
Transplanting human umbilical cord blood-derived MSCs into mice with E. coli-induced lung injury significantly improves survival and reduces lung damage mainly through anti-inflammatory effects.
Supporting Evidence
- MSC transplantation increased survival rates in mice with E. coli-induced lung injury.
- Lung injury scores were significantly lower in MSC-treated mice compared to controls.
- Inflammatory cytokine levels were reduced in the lungs of MSC-treated mice.
- MSC treatment improved lung water content, indicating better lung function.
Takeaway
Scientists found that giving special cells from umbilical cords to mice with lung problems helped them get better and live longer.
Methodology
Eight-week-old male ICR mice were divided into groups and given E. coli to induce lung injury, followed by intratracheal administration of MSCs or control treatments, with survival and lung inflammation assessed over 7 days.
Limitations
Tissue examinations were only performed on surviving animals, which may underestimate the therapeutic effect of MSCs.
Participant Demographics
Eight-week-old male ICR mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website